ATE309265T1 - Peptidverbindung, die von einem verschobenen offenen leserahmen des ice-gens abstammt - Google Patents

Peptidverbindung, die von einem verschobenen offenen leserahmen des ice-gens abstammt

Info

Publication number
ATE309265T1
ATE309265T1 AT00946023T AT00946023T ATE309265T1 AT E309265 T1 ATE309265 T1 AT E309265T1 AT 00946023 T AT00946023 T AT 00946023T AT 00946023 T AT00946023 T AT 00946023T AT E309265 T1 ATE309265 T1 AT E309265T1
Authority
AT
Austria
Prior art keywords
peptide compound
reading frame
open reading
compound derived
ice gene
Prior art date
Application number
AT00946023T
Other languages
German (de)
English (en)
Inventor
Christophe Ronsin
Veronique Scott
Frederic Triebel
Original Assignee
Roussy Inst Gustave
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussy Inst Gustave filed Critical Roussy Inst Gustave
Application granted granted Critical
Publication of ATE309265T1 publication Critical patent/ATE309265T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00946023T 1999-06-28 2000-06-27 Peptidverbindung, die von einem verschobenen offenen leserahmen des ice-gens abstammt ATE309265T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9908224A FR2795415B1 (fr) 1999-06-28 1999-06-28 Compose peptidique derive d'une orf decalee du gene ice
PCT/FR2000/001791 WO2001000784A2 (fr) 1999-06-28 2000-06-27 COMPOSE PEPTIDIQUE DERIVE D'UNE ORF DECALEE DU GENE iCE

Publications (1)

Publication Number Publication Date
ATE309265T1 true ATE309265T1 (de) 2005-11-15

Family

ID=9547371

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00946023T ATE309265T1 (de) 1999-06-28 2000-06-27 Peptidverbindung, die von einem verschobenen offenen leserahmen des ice-gens abstammt

Country Status (9)

Country Link
US (1) US6875844B1 (enExample)
EP (1) EP1192179B1 (enExample)
JP (1) JP2003503042A (enExample)
AT (1) ATE309265T1 (enExample)
AU (1) AU5992500A (enExample)
CA (1) CA2377433A1 (enExample)
DE (1) DE60023891T2 (enExample)
FR (1) FR2795415B1 (enExample)
WO (1) WO2001000784A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same
US7597894B2 (en) 2003-03-05 2009-10-06 Dendreon Corporation Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease
EP2044949A1 (en) 2007-10-05 2009-04-08 Immutep Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response
CN104630149B (zh) * 2013-11-08 2018-08-21 中国科学院广州生物医药与健康研究院 外源线粒体导入到哺乳动物细胞中的方法
GB201322626D0 (en) 2013-12-19 2014-02-05 Immutep S A Combined preparations for the treatment of cancer
GB201500374D0 (en) 2015-01-09 2015-02-25 Immutep S A Combined preparations for the treatment of cancer
WO2018035311A1 (en) * 2016-08-19 2018-02-22 Gray John T Compositions and methods for modulating gene expression using reading frame surveillance

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997029183A2 (en) * 1996-02-08 1997-08-14 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Methods and compositions for transforming dendritic cells and activating t cells
AU7724398A (en) * 1997-06-06 1998-12-21 Regents Of The University Of California, The A melanoma associated antigen, t cell epitopes thereof and methods of using sa me
DE69837273T2 (de) * 1997-10-08 2008-01-31 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Menschliches krebsantigen ny eso-1/cag-3 und dazu kodierendes gen

Also Published As

Publication number Publication date
FR2795415B1 (fr) 2003-09-05
EP1192179A2 (fr) 2002-04-03
DE60023891D1 (de) 2005-12-15
WO2001000784A2 (fr) 2001-01-04
JP2003503042A (ja) 2003-01-28
US6875844B1 (en) 2005-04-05
FR2795415A1 (fr) 2000-12-29
AU5992500A (en) 2001-01-31
WO2001000784A3 (fr) 2001-07-26
DE60023891T2 (de) 2006-07-27
CA2377433A1 (fr) 2001-01-04
EP1192179B1 (fr) 2005-11-09

Similar Documents

Publication Publication Date Title
ATE185572T1 (de) Kombinatorische pna-bibliotheken und verbesserte syntheseverfahren
EP1103564A4 (en) CANCER ANTIGEN, BASED ON TUMOR SUPPRESSIVE GENEVA PRODUCT WT1
BG104819A (en) Substituted indolealkanoic acids
WO1999024460A3 (en) Dipeptide nitriles
CY1109450T1 (el) Μεθοδοι παρασκευης πεπτιδιων
ID21956A (id) Asam n-(aril dan atau heteroarilasetil) amino ester, komposisi farmasi yang mengandungnya, dan metoda untuk menghambat pelepasan betha-amiloid peptida dan atau sintesanya dengan menggunakan senyawa tersebut
WO2001079444A3 (en) Albumin fusion proteins
IL147271A (en) Isolated peptide ligands that bind to her2
AU4710499A (en) Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use ofsuch compounds
BR9610922A (pt) Peptìdios rio-substituìdos como inibidores para metalo-proteinases e liberação de tnf
NO20001556L (no) Kontrastmidler for infarkt- og nekroseavbildning
WO1998022441A3 (en) N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions, and methods for inhibiting beta-amyloid peptide and/or its synthesis
ATE309265T1 (de) Peptidverbindung, die von einem verschobenen offenen leserahmen des ice-gens abstammt
DK1114861T3 (da) LY6H-gen
DE69808475D1 (de) Aminosäurederivate zur behandlung von schlaganfall
TW200517125A (en) Pharmaceutical composition for treatment of solid cancers
BG107553A (en) Aminoalkenylbenzoyl-benzofuran or benzothiophene derivatives, methods for preparing same and compositions containing same
WO2001092468A3 (en) Novel compositions for the expression of the human peptide histidine transporter 1 and methods of use thereof
WO1997046672A3 (en) Antisense nucleic acids and hammerhead ribozymes
WO2004094462A3 (en) Methods of peptide preparation
WO2002007740A3 (de) Schlangentoxin und dessen verwendung als arzneimittel
DE69812597D1 (de) Peptide zur Inhibition von HPV E7 Proteinen
WO2002033058A3 (en) Novel cysteine proteases and uses thereof
MXPA03010739A (es) Moleculas de marcador endotelial tumoral 7-alfa y uso de las mismas.
WO2002034901A8 (en) Protein kinase

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1192179

Country of ref document: EP

REN Ceased due to non-payment of the annual fee